New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

AstraZeneca PLC

AZN

Healthcare Drug Manufacturers General

AstraZeneca PLC’s revenue for fiscal 2025 (year ended December 2025) was $58.7 billion, up 8.63% from fiscal 2024.

Revenue
+6.70%
EPS
+23.5%
Free cash flow
+1.99%
Total debt
+1.75%

Quarter to September 2026, against a year earlier

175.60 0.15 +0.09%
Market cap
$272.1B
P/E
24.6×
Fwd P/E FY26e
24.2×
Dividend yield
1.83%
F-score
9/9
ROIC
12.3%
Net debt / EBITDA
1.1×
Payout ratio
0.5×

What it owns vs. what it owes Q3 FY2026, Sep 30, 2026

It owes $23.2B more in debt than it holds in cash and short-term investments. Debt has risen from $27.8B to $31.4B since Q4 FY25. Shareholders’ equity is 43.2% of the balance sheet. What is a balance sheet?

Sep 30, 2026 · total $119.9B

Owns

$88.5BLong-term assets
$23.3BOther short-term assets
$8.2BCash & short-term investments

Funded by

$51.8BShareholders’ equity
$36.7BOther liabilities
$31.4BDebt

Debt is 26.2% of the total; shareholders’ equity 43.2%.

Net debt has held near 19% of assets since Q4 FY25.

Total assetsNet debt (debt less cash)Net debt ÷ assets (right axis)
Assets and net debt, four quarters
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Total assets$114.1B$114.0B$115.8B$119.9B
Net debt (debt less cash)$22.0B$24.3B$24.4B$23.2B
Net debt ÷ assets (right axis)19.3%21.3%21.1%19.4%
Older periods Dec '25 Mar '26 Jun '26 Sep '26
Total current assets
28,723.00 29,613.00 27,965.00 31,448.00
Total non-current assets
85,351.00 84,402.00 87,868.00 88,474.00
Total Assets
114,074.00 114,015.00 115,833.00 119,922.00
Total current liabilities
30,617.00 32,570.00 31,553.00 31,267.00
Total non-current liabilities
34,738.00 34,061.00 33,910.00 36,841.00
Total liabilities
65,355.00 66,631.00 65,463.00 68,108.00
Common Equity (Total)
48,719.00 47,384.00 50,370.00 51,814.00
Shareholders Equity (Total)
48,719.00 47,384.00 50,370.00 51,814.00
Total Debt
27,819.00 32,030.00 29,491.00 31,414.00

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026